119 related articles for article (PubMed ID: 6575488)
1. Treatment of acute lymphoblastic leukemia in adults with combination chemotherapy incorporating vindesine and prednisolone.
Saito Y; Uzuka Y
Tohoku J Exp Med; 1983 Apr; 139(4):421-2. PubMed ID: 6575488
[TBL] [Abstract][Full Text] [Related]
2. [Vindesine plus L-asparaginase and prednisolone therapy (VDS-VLP therapy) for remission induction in children with relapsed acute lymphoblastic leukemia].
Hara T; Koike K; Tsukada M; Komiyama A; Akabane T
Rinsho Ketsueki; 1983 May; 24(5):540-6. PubMed ID: 6577209
[No Abstract] [Full Text] [Related]
3. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
[TBL] [Abstract][Full Text] [Related]
4. Treatment of the blastic crisis of chronic myelogenous leukemia with the combination of vindesine and prednisolone, and cytosine arabinoside.
Uzuka Y; Saito Y
Tohoku J Exp Med; 1983 Apr; 139(4):419-20. PubMed ID: 6575487
[TBL] [Abstract][Full Text] [Related]
5. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
[TBL] [Abstract][Full Text] [Related]
6. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M
Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018
[TBL] [Abstract][Full Text] [Related]
7. [Phase II study of Vindesine in patients with hematological malignancy].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1536-7. PubMed ID: 6347082
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic myelogenous leukemia in blastic crisis with chemotherapy incorporating vindesine-prednisolone.
Uzuka Y; Saito Y
Cancer Treat Rep; 1985 Nov; 69(11):1297-9. PubMed ID: 3867403
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of chronic myelogenous leukemia in blastic crisis--vindesine, cytosine arabinoside prednisolone combination therapy].
Uzuka Y; Saito Y; Takahash H; Komatsu M
Gan To Kagaku Ryoho; 1984 May; 11(5):1064-70. PubMed ID: 6586112
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
Hellriegel KP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
[No Abstract] [Full Text] [Related]
11. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
[TBL] [Abstract][Full Text] [Related]
12. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
Bayssas M; Gouveia J; Ribaud P; Musset M; de Vassal F; Pico JL; de Luca L; Misset JL; Machover D; Belpomme D; Schwarzenberg L; Jasmin C; Hayat M; Mathé G
Cancer Chemother Pharmacol; 1979; 2(4):247-55. PubMed ID: 287569
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of acute myelogenous leukemia with eosinophilia which progressed into complete remission with the treatment mainly consisting of vindesine and prednisolone].
Yamada O; Naohara T; Aoyama M; Totsuka K; Muto K; Ito N; Otani T; Oshimi K; Mizoguchi H; Okada M
Rinsho Ketsueki; 1983 Jan; 24(1):45-50. PubMed ID: 6573521
[No Abstract] [Full Text] [Related]
14. Phase II trial of vindesine in patients with acute leukemia.
Sklaroff RB; Arlin Z; Young CW
Cancer Treat Rep; 1979; 63(11-12):2063-5. PubMed ID: 294307
[TBL] [Abstract][Full Text] [Related]
15. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary data on treatment with Vindesine in relapses of acute lymphoblastic leukemia].
Jankovic M; Uderzo C; Rossi MR; Locasciulli A; Conter V; Masera G
Haematologica; 1981 Oct; 66(5):710-2. PubMed ID: 6796480
[No Abstract] [Full Text] [Related]
17. Vindesine effect in myeloid leukemia.
Baccarani M; Zaccaria A; Corbelli G; Tura S
Cancer Chemother Pharmacol; 1982; 8(3):255-9. PubMed ID: 6957273
[TBL] [Abstract][Full Text] [Related]
18. Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
Vats TS; Mehta P; Trueworthy RC; Smith SD; Klopovich P
Cancer; 1981 Jun; 47(12):2789-92. PubMed ID: 6942907
[TBL] [Abstract][Full Text] [Related]
19. Sequential combination of methotrexate and vindesine in previously treated children with acute leukemia. A phase I-II study.
Miller LP; Hancock C; Miller DR; Chello PL; Sirotnak FM; Tan CT
Am J Clin Oncol; 1984 Oct; 7(5):465-70. PubMed ID: 6594925
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute lymphoblastic leukemia].
Paolucci G; Rosito P
Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
[No Abstract] [Full Text] [Related]
[Next] [New Search]